Exact Sciences (EXAS) Shares Surge As New Licensing Agreement Boosts Market Confidence
Shares of Exact Sciences Corporation (NASDAQ: EXAS) are on a notable increase today, following the announcement of a new licensing agreement. In the current market session, EXAS stock was trading 23.20% higher to a per share price of $56.28. Strategic Licensing Agreement with TwinStrand Biosciences With TwinStrand Biosciences, Exact Sciences has secured the rights to […]